- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04061642
A Feasibility Study of an AI-Powered Clinical Decision Aid for Personalized Depression Treatment Selection
A Feasibility Study of a Hybrid-Classic/Deep-Learning Enabled Clinical Decision Aid for Personalized and Individualized Pharmacological Depression Treatment Selection
Studieoversikt
Detaljert beskrivelse
Hypothesis 1. There will not be a significant difference in measured non-initial intake appointment lengths between the baseline period and the appointment length measured at two and four months after introduction of the study software and CDA.
Hypothesis 2. Physicians will not subjectively report that using the CDA and study software increased the length of their appointments.
Hypothesis 3. At least 66% of patients and 66% of physicians will rate the trustworthiness of the CDA as a 4 or 5 on a 5 point Likert scale (with higher ratings indicating greater trust).
Hypothesis 4. At least 66% of patients and 66% of physicians will rate the overall usability of the CDA as a 4 or 5 on a 5 point Likert scale (with higher ratings indicating greater usability).
Hypothesis 5. At least 70% of physicians and 65% of patients will still be using the application regularly by the end of the study. For physicians, regularly will be defined as the application being used in every study-related visit. For patients regularly will be defined as completing at least one PHQ-9 and GAD-7 questionnaire on the application per week.
Exploratory hypothesis: Based on our machine learning results to date, we expect between 40-50% of patients starting a new treatment for depression and whose treatment follows the highest probability treatment output by the CDA to remit within 14 weeks. This is exploratory, and the study is not necessarily powered to demonstrate this.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Quebec
-
Verdun, Quebec, Canada, H4H 1R3
- Douglas Mental Health University Institute
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- All patients of the physicians in the study are diagnosed with major depressive disorder by a physician using DSM-V criteria.
- All participants must be able to provide informed consent.
- Contraception will be used as per established clinical guidelines and usual clinical practice for medications known to cause birth defects. The medications prescribed and the use of and type of contraception will be determined by the physicians in the study in consultation with their patients as would usually occur in clinical practice.
Exclusion Criteria:
- Bipolar disorder type 1 or 2, as the data we have used to train the model does not allow for generalization to bipolar disorder (either pre-existing or as diagnosed according to DSM-5 criteria).
- Inability or unwillingness of individual to give informed consent.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Enhetens gjennomførbarhet
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Clinical Decision Aid
|
The Clinical Decision Aid is a predictive model that takes as input individual patient characteristics, called 'features', which are inputted by the physician or by patient self-report, and outputs a list of all possible treatments, with each treatment associated with a predicted efficacy (likelihood to achieve response and likelihood to achieve remission, each expressed as a percentage).
The treatments, which may include any approved treatment for depression, will be ordered by efficacy and presented to the physician.
Lifestyle interventions, such as exercise or mindfulness, which have an evidence base, but do not require formal regulatory approval, will also be outputted.
The system will additionally produce a side effect profile for each pharmacological treatment recommended, including known side effects, modified by a prediction about which side effects may be more likely for a given individual based on their individual characteristics.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Subjective length of outpatient visits
Tidsramme: Through study completion, 6 months
|
Through study completion, 6 months
|
|
Objective length of outpatient visits
Tidsramme: Through study completion, 6 months
|
Through study completion, 6 months
|
|
Physician retention rates
Tidsramme: Through study completion, 6 months
|
Through study completion, 6 months
|
|
Patient retention rates
Tidsramme: Through study completion, 6 months
|
Through study completion, 6 months
|
|
Patient self-rated experience using the study software
Tidsramme: Through study completion, 6 months
|
We will be using our Clinical Decision Aid Feasibility Questionnaire (Version 1), a descriptive questionnaire with 5-point Likert scales (with higher values representing better outcomes) and narrative questions about experience using the tool.
|
Through study completion, 6 months
|
Samarbeidspartnere og etterforskere
Sponsor
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- IUSMD-19-08
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Clinical Decision Aid
-
Madigan Army Medical CenterTelemedicine & Advanced Technology Research Center; Analytics4Medicine,...Ukjent
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) og andre samarbeidspartnereFullført
-
Washington University School of MedicineNational Institute on Minority Health and Health Disparities (NIMHD); National...FullførtHelsekunnskap | Helseforsikring | Tilgjengelighet for helsetjenester | Informert beslutningstakingForente stater
-
Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI)Fullført
-
University of California, San FranciscoFullførtHypertensjon | Nyresvikt, kroniskForente stater
-
Washington University School of MedicineRobert Wood Johnson FoundationFullført
-
Aifred HealthMcGill UniversityFullført
-
HealthPartners InstituteNational Heart, Lung, and Blood Institute (NHLBI)FullførtHypertensjon | Overvekt | Pre-hypertensjonForente stater
-
Abdul Latif Jameel Poverty Action LabIcahn School of Medicine at Mount SinaiAvsluttetCT- og MR-bildebestillingerForente stater
-
Abdul Latif Jameel Poverty Action LabMassachusetts Institute of Technology; Aurora Health Care; Laura and John...FullførtCT-, MR-, NM- og PET-bildebestillingerForente stater